India records highest number of failed doping tests among countries with 2,000 or more tests: WADA report – Firstpost
The National Anti-Doping Agency of India (NADA) analyzed 3,865 samples, of which 125 returned abnormal analytical results.
India recorded the highest percentage of adverse analytical findings (AAF), or drug test failures, among countries with 2,000 samples or more, ahead of South Africa, according to a report by the World Anti-Doping Agency (WADA) for 2022.
India’s National Anti-Doping Agency (NADA) analyzed 3,865 samples (a combination of urine and blood) during this period, of which 125 returned abnormal analytical results. This represents 3.2 percent of samples, WADA said in its report on 2022 testing figures.
Among countries that had more than 2,000 samples, South Africa returned the second highest percentage of adverse results – 2.9% out of 2,033 samples tested.
Third place went to Kazakhstan with 1.9 percent of its testing pool of 2,174 samples returning unfavorable results.
The fourth highest percentage comes from Norway and the United States. While the United States tested 6,782 samples for an adverse outcome rate of 1.2%, Norway’s number was 2,075 (also for an AAF rate of 1.2%).
In terms of number of samples tested, India is 11th on the list, but the number of anti-doping violations was higher than major sporting nations like Russia (85), USA (84), Italy (73) and France (72).
China tested the largest number of samples – 19,228 – during the period, with an abnormal result rate of 0.2 percent.
Germany tested 13,653 samples, of which 0.3 percent tested positive for banned substances.
RUSADA, the Russian anti-doping agency, considered non-compliant by WADA, tested 10,186 samples with a percentage of adverse analytical results of 0.8 percent.
“WADA’s annual report on doping control figures is the most comprehensive overview of all doping control samples…” WADA Director General Olivier Niggli said in a statement.
“WADA is pleased to see that the number of doping controls in the testing figures continues to increase across the board and is closest to pre-pandemic (2019) levels.
“The Testing Figures Report is an important tool for collaboration between anti-doping organizations,” he added.
